Catalent to use GPEx cell line tech to make Amarantus' protein candidate
Amarantus BioScience has selected Catalent to make the protein mesencephalic-astrocyte-derived neurotrophic factor (MANF) for its Phase I candidate.
Archives for May 17, 2015
Dr Reddy’s yen for growth: Indian generics and API firm plans to partner in Japan
Dr Reddy’s has set out to build in the Japanese market days after revealing that higher generic and API sales elsewhere had been pegged back by currency fluctuations.
US FDA investigates AZ, J&J and B-I's type 2 diabetes drugs after adverse events
Diabetes drugs made by J&J, AstraZeneca and Boehringer-Ingelheim are being investigated by the US FDA after 20 cases of acidosis resulting in hospitalisation were recorded.
Xention aims to cash in ion channel knowhow through new CRO
Heart drug developer Xention has launched a contract screening business designed for drug industry customers seeking ion channel services.
Hospira approval puts Pfizer on track to close $17bn deal by year's end
Pfizer is set to close its $17bn (€15bn) acquisition by the end of the year after receiving the thumbs up from Hospira shareholders.
EMA drug reviews must be independent of pharma influence as an example to others, says AMF
The EMA's assessment of new drugs must be independent of pharmaceutical industry influence as an example to others, according to the Access to Medicines Foundation (AMF)